Simcere Pharma

company

About

Simcere Pharma is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market.

  • 1001 - 5000

Details

Last Funding Type
Series B
Last Funding Money Raised
¥600M
Industries
Biotechnology,Manufacturing
Founded date
Jan 1, 1995
Number Of Employee
1001 - 5000
Operating Status
Active

Founded on 28th March 1995, Simcere swiftly evolved from being a pure distributor of pharmaceutical products to become a leading manufacturer and supplier of drugs in China's rapidly growing pharmaceutical market. Simcere currently operates five GMP-certified manufacturing facilities, two nationwide sales and marketing subsidiaries, a research and development center and manages over 4,000 employees. They are the first Chinese chemical and biological drug company to list on the New York Stock Exchange with IPO proceeds reaching US$ 261 million.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥600M
Simcere Pharma has raised a total of ¥600M in funding over 2 rounds. Their latest funding was raised on Jun 4, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 4, 2021 Series B ¥600M 4 CITIC Medical Fund Detail

Investors

Number of Lead Investors
Number of Investors
1
4
Simcere Pharma is funded by 4 investors. CITIC Medical Fund and Tianhui Chuangtou are the most recent investors.
Investor Name Lead Investor Funding Round
CITIC Medical Fund Yes Series B
Tianhui Chuangtou Series B
Hongcheng Capital Series B
Nanjing Innovation Capital Group Series B